Literature DB >> 33712254

Renal injury after open versus laparoscopic non-cardiac surgery: a retrospective cohort analysis.

Hani Essber1, Barak Cohen2, Amanda S Artis3, Steve M Leung1, Kamal Maheshwari4, Mohammad Zafeer Khan1, Daniel I Sessler1, Alparslan Turan4, Kurt Ruetzler5.   

Abstract

BACKGROUND: Laparoscopic surgical approaches enhance recovery, reduce postoperative pain, and shorten hospital length-of-stay. Nevertheless, increased intra-abdominal pressure is associated with decreased renal blood flow, renal hypoxia and acute kidney injury. When combined with Trendelenburg positioning, renal function may further deteriorate. We tested the primary hypothesis that the combination of laparoscopic surgical approach and Trendelenburg position is associated with larger reductions in estimated Glomerular Filtration Rate (eGFR) within the initial 48 postoperative hours compared to open surgery without Trendelenburg positioning. Secondarily, we tested, if laparoscopic procedures are associated with greater incidence of postoperative acute kidney injury.
METHODS: Adults who had laparoscopic colorectal surgery in Trendelenburg position at the Cleveland Clinic Main Campus from 2009 to 2016 were propensity-matched to patients who had comparable open procedures. Patients with pre-existing renal impairment were excluded.
RESULTS: Among 7,357 eligible patients, 1,846 laparoscopic cases with Trendelenburg were matched to 1,846 open cases. No association was found between laparoscopic approach and postoperative eGFR. A significant protective effect of the laparoscopic procedure on the odds of having AKI was found. Patients who had laparoscopic surgeries were an estimated 0.70 (95% CI 0.55, 0.90, pHolm-adj = 0.006) times as likely to have AKI as open surgical patients.
CONCLUSION: Despite compelling potential mechanisms, laparoscopic approach with Trendelenburg position in adult colorectal surgeries did not worsen postoperative eGFR, and actually reduced postoperative acute kidney injury. Given the other advantages of laparoscopic surgery, the approach should not be avoided for concerns about renal injury.
Copyright © 2021 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Anesthesia; Laparoscopy

Mesh:

Year:  2020        PMID: 33712254      PMCID: PMC9373244          DOI: 10.1016/j.bjane.2020.12.008

Source DB:  PubMed          Journal:  Braz J Anesthesiol        ISSN: 0104-0014


Introduction

Laparoscopy causes less tissue trauma than open surgery, thereby reducing neuroendocrinic and inflammatory responses as well as postoperative pain. Laparoscopic procedures are also usually less expensive than open surgery since patients are discharged earlier.1, 2 Laparoscopy is generally considered safe, with complications mostly resulting from traumatic trocar induction. However, intra-abdominal insufflation of carbon dioxide or oxygen is needed to provide adequate visualization of the surgical field and the consequent increase in intra-abdominal pressure can impair cardiovascular, respiratory, and renal systems. Peritoneal insufflation applies pressure to renal parenchyma and blood vessels, stimulates antidiuretic hormone (vasopressin) secretion, increases activity of the renin-angiotensin-aldosterone axis, promotes release of catecholamines and endothelin, increases vascular resistance, compresses the abdominal vena cava, and reduces cardiac output.3, 4 The kidneys may be especially sensitive to intra-abdominal pressure, and both animal and human studies suggest that even short durations of slightly increased intra-abdominal pressure can impair renal function.6, 7, 8 As might thus be expected, renal impairment is associated with the degree of pneumoperitoneal pressure and the duration of surgery.3, 9 Surgical positioning may also contribute to Acute Kidney Injury (AKI). Trendelenburg positioning increases intracranial and intraocular pressures by promoting venous return to the heart, but simultaneously decreases renal perfusion. Trendelenburg position nearly doubles central venous pressure which potentially worsens congestive heart failure or even promotes myocardial infarction.10, 11, 12 Trendelenburg position is widely used in laparoscopic colorectal procedures to improve surgical exposure, and is often both steep and prolonged. Patients having colorectal laparoscopic procedures might therefore be at special risk for AKI consequent to both pneumoperitoneum and Trendelenburg positioning. We therefore compared the risk of postoperative AKI between laparoscopic and open colorectal surgery. Specifically, we tested the primary hypothesis that the combination of laparoscopic surgical approach and Trendelenburg position is associated with larger reductions in estimated Glomerular Filtration Rate (eGFR) within the initial 48 postoperative hours compared to open surgery without Trendelenburg positioning. Secondarily, we tested the hypothesis that laparoscopic surgical approach and Trendelenburg position is associated with a greater incidence of postoperative AKI during the initial 7 postoperative days.

Methods

Our analysis was conducted with IRB approval and waived individual consent. Data were obtained from the Cleveland Clinic Perioperative Health Documentation System. Analysis was restricted to index surgeries for adults (18–85 years old) who had scheduled colorectal surgery at the Cleveland Clinic Main Campus, Ohio, United Staates. The Cleveland Clinic is a large tertiary academic healthcare institution providing all kinds of surgeries. Only major therapeutic and diagnostic surgeries with general or combined regional and general anaesthesia were considered. We excluded patients who had surgery lasting fewer than 90 minutes, laparoscopic surgery not in Trendelenburg position, and open surgery in Trendelenburg position. We also excluded patients who had preoperative renal insufficiency (defined as creatinine > 1.6 mg.dL-1), missing outcome data, fewer than 3 days of hospitalization, preoperative sepsis, or emergency surgeries. The exposure of interest was the combination of laparoscopic surgery performed in Trendelenburg position (“laparoscopic”) versus open approach without Trendelenburg positioning (“open”). Our primary outcome was postoperative eGFR and our secondary outcome was the incidence of Acute Kidney Injury (AKI). Postoperative eGFR was defined using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. AKI was defined using the AKIN criteria which is based on serum creatinine level at baseline (the last measurement within 30 days prior to surgery) and maximal serum level during the first 7 postoperative days or discharge, whichever occurred first. As per Walsh et al., we extended the normal 48-h window originally used to capture renal events to seven postoperative days to better characterize the postoperative period. And as usual in perioperative studies, we did not consider urine output which is rarely available. Laparoscopic patients were matched to open patients using propensity matching. We first estimated the propensity score (probability of having laparoscopic surgery) for each patient using multivariable logistic regression given the baseline confounders listed in Table 1 (except colorectal surgical type, which was exactly matched in the next step). We then used a 1:1 greedy matching algorithm to match patients on colorectal procedure type and propensity score. We set the maximum allowable propensity score difference to 0.2 standard deviation of the logit of the propensity score (0.2 × SD [logit (propensity score)] = 1.11).
Table 1

Summary statistics of baseline and intraoperative characteristics.

VariableAll patients
Matched patients
LaparoscopicOpenASDLaparoscopicOpenASD
(n = 1976)(n = 5531)(n = 1846)(n = 1846)
Baseline variables
Age, yearsb51 ± 1752 ± 160.0351 ± 1752 ± 160.02
BMI, kg. m-2a, b27.1 ± 6.226.8 ± 6.40.0427.0 ± 6.227.0 ± 6.40.01
Risk Stratification Index (RSI)b−4.9 ± 0.76−4.9 ± 0.720.03−4.9 ± 0.76−4.9 ± 0.730.02
Preoperative eGFR, mL. min-1/1.73 m2 b92.6 ± 22.391.7 ± 23.80.0492.7 ± 21.692.4 ± 22.20.01
Preoperative hemoglobina, b12.9 ± 2.012.6 ± 2.00.1712.9 ± 2.012.9 ± 1.90.02
Number of antihypertensive agentsc0 [0,1]0 [0,1]0.000 [0,1]0 [0,1]0.04
Female sex1048 (53.0)2834 (51.2)0.04982 (53.2)968 (52.4)0.02
Aspirin154 (7.8)398 (7.2)0.02144 (7.8)136 (7.4)0.02
Calcium-antagonists103 (5.2)312 (5.6)0.0293 (5.0)96 (5.2)0.01
Beta-blocker210 (10.6)639 (11.6)0.03197 (10.7)186 (10.1)0.02
Diuretics213 (10.8)510 (9.2)0.05196 (10.6)181 (9.8)0.03
ACE-Inhibitors170 (8.6)416 (7.5)0.04159 (8.6)150 (8.1)0.02
AT II-antagonists83 (4.2)169 (3.1)0.0668 (3.7)70 (3.8)0.01
Statins239 (12.1)529 (9.6)0.08224 (12.1)210 (11.4)0.02
Proton-pump inhibitor318 (16.1)981 (17.7)0.04295 (16.0)268 (14.5)0.04
NSAIDs132 (6.7)421 (7.6)0.04126 (6.8)129 (7.0)0.01
Immunosuppressants (cyclosporine, tacrolimus)67 (3.4)181 (3.3)0.0159 (3.2)54 (2.9)0.02
Steroids465 (23.5)941 (17.0)0.16416 (22.5)361 (19.6)0.07
History of MI82 (4.1)233 (4.2)0.0076 (4.1)81 (4.4)0.01
History of CHF135 (6.8)422 (7.6)0.03131 (7.1)131 (7.1)0.00
History of PVD67 (3.4)181 (3.3)0.0162 (3.4)57 (3.1)0.02
History of stroke64 (3.2)198 (3.6)0.0262 (3.4)57 (3.1)0.02
Pulmonary circulation disease18 (0.91)82 (1.5)0.0518 (0.98)18 (0.98)0.00
Liver disease40 (2.0)132 (2.4)0.0237 (2.0)44 (2.4)0.03
Hypothyroidism193 (9.8)558 (10.1)0.01183 (9.9)186 (10.1)0.01
Hypertension652 (33.0)1810 (32.7)0.01610 (33.0)593 (32.1)0.02
Diabetes194 (9.8)627 (11.3)0.05180 (9.8)190 (10.3)0.02
Smoker905 (45.8)2820 (51.0)0.10847 (45.9)890 (48.2)0.05
Obesity279 (14.1)736 (13.3)0.02263 (14.2)248 (13.4)0.02
Chronic obstructive pulmonary disease199 (10.1)655 (11.8)0.06188 (10.2)195 (10.6)0.01
Dyslipidemia449 (22.7)1030 (18.6)0.10417 (22.6)406 (22.0)0.01
Angina decubitus3 (0.15)4 (0.07)0.023 (0.16)2 (0.11)0.01
Coronary artery disease106 (5.4)241 (4.4)0.0597 (5.3)91 (4.9)0.01
Cardiac dysrhythmias85 (4.3)319 (5.8)0.0781 (4.4)78 (4.2)0.01
Race0.080.03
Caucasian1818 (92.0)4962 (89.7)1697 (91.9)1685 (91.3)
African American107 (5.4)397 (7.2)101 (5.5)105 (5.7)
Other51 (2.6)172 (3.1)48 (2.6)56 (3.0)
Surgeon1.000.14
Surgeon 125 (1.3)688 (12.4)25 (1.4)25 (1.4)
Surgeon 2224 (11.3)105 (1.9)146 (7.9)92 (5.0)
Surgeon 3139 (7.0)272 (4.9)137 (7.4)149 (8.1)
Surgeon 4122 (6.2)262 (4.7)119 (6.4)145 (7.9)
Surgeon 552 (2.6)364 (6.6)52 (2.8)46 (2.5)
Surgeon 6152 (7.7)553 (10.0)151 (8.2)158 (8.6)
Surgeon 7226 (11.4)332 (6.0)215 (11.6)223 (12.1)
Surgeon 8100 (5.1)238 (4.3)99 (5.4)98 (5.3)
Surgeon 9142 (7.2)301 (5.4)140 (7.6)170 (9.2)
Surgeon 100 (0.0)933 (16.9). (.). (.)
Other Surgeon794 (40.2)1483 (26.8)762 (41.3)740 (40.1)
Colorectal procedure type0.610.00
Colostomy or colorectal resection1845 (93.4)3990 (72.1)1717 (93.0)1717 (93.0)
Ileostomy, small bowel resection, and other enterostomy119 (6.0)929 (16.8)117 (6.3)117 (6.3)
Hernia repair1 (0.05)153 (2.8)1 (0.05)1 (0.05)
Exploratory laparotomy0 (0.0)61 (1.1)0 (0.0)0 (0.0)
Excision; lysis peritoneal adhesions3 (0.15)98 (1.8)3 (0.16)3 (0.16)
Other procedures8 (0.40)300 (5.4)8 (0.43)8 (0.43)
ASA physical status0.110.01
128 (1.4)38 (0.69)25 (1.4)23 (1.2)
2887 (44.9)2255 (40.8)821 (44.5)838 (45.4)
3986 (49.9)2969 (53.7)930 (50.4)914 (49.5)
475 (3.8)269 (4.9)70 (3.8)71 (3.8)
Year of the surgery0.370.09
2009199 (10.1)966 (17.5)197 (10.7)247 (13.4)
2010208 (10.5)897 (16.2)206 (11.2)222 (12.0)
2011191 (9.7)761 (13.8)185 (10.0)220 (11.9)
2012284 (14.4)745 (13.5)265 (14.4)246 (13.3)
2013306 (15.5)656 (11.9)283 (15.3)256 (13.9)
2014311 (15.7)647 (11.7)284 (15.4)250 (13.5)
2015132 (6.7)274 (5.0)125 (6.8)121 (6.6)
2016345 (17.5)585 (10.6)301 (16.3)284 (15.4)

Data are given as n (column %) unless otherwise indicated.

Variables with ASD > 0.1 after matching were considered imbalanced and thus included in subsequent multivariable regression models to control for residual confounding.

Data not available for all subjects before matching. Missing values: Body Mass Index = 77, Preoperative Hemoglobin = 73, Time weighted average MAP = 1.

Data are given as mean ± SD.

Data are given as median [Q1, Q3].

Summary statistics of baseline and intraoperative characteristics. Data are given as n (column %) unless otherwise indicated. Variables with ASD > 0.1 after matching were considered imbalanced and thus included in subsequent multivariable regression models to control for residual confounding. Data not available for all subjects before matching. Missing values: Body Mass Index = 77, Preoperative Hemoglobin = 73, Time weighted average MAP = 1. Data are given as mean ± SD. Data are given as median [Q1, Q3]. Balance between laparoscopic and open on a priori selected pre-surgical confounder variables before and after matching was assessed using the standardized difference (i.e., the difference in means or proportions divided by the pooled SD). A pre-specified conservative criterion of an Absolute Standardized Difference (ASD) greater than 0.1 was used to indicate imbalance. Confounding variables with ASD > 0.1 after matching were included in all regression models comparing matched laparoscopic to open cases on our outcomes to adjust for any residual confounding which remained after matching. Data summaries for intraoperative measures are listed in Table 2. These variables were excluded from the propensity score analysis and all subsequent regression models since some are characteristics of either the laparoscopic or open surgical procedure and are thus mediators rather than confounders. Furthermore, intraoperative variables cannot be considered true confounders given they do not precede the exposure of interest.
Table 2

Summary Statistics of Intraoperative Characteristics.

VariableAll patients
Matched patients
LaparoscopicOpenASDLaparoscopicOpenASD
(n = 1976)(n = 5531)(n = 1846)(n = 1846)
Duration of surgery (min)259 (90,722)199 (90,942)0.56258 (90,722)208 (90,942)0.47
Epinephrine (mg)0.0 (0.0,0.1)0.0 (0.0,11.3)0.060.0 (0.0,0.1)0.0 (0.0,1.0)0.06
Ephedrine (mg)0 (0.85)0 (0.90)0.070 (0.85)0 (0.90)0.07
Norepinephrine (mg)0.0 (0.0,1.4)0.0 (0.0,4.9)0.060.00 (0.0,1.4)0.00 (0.0,1.4)0.04
Phenylephrine (mg)0.1 (0.0,27.2)0.1 (0.0,29.7)0.010.1 (0.0,27.2)0.1 (0.0,26.0)0.02
Urine output300 (0, 3,850)250 (0,4460)0.28300 (0, 3,850)225 (0, 4,460)0.36
Estimated blood loss100 (0, 4,300)150 (0, 16,100)0.30100 (0, 4,300)100 (0, 8,500)0.15
RBC transfusion (cc)0 (0.2814)0 (0.10608)0.260 (0.2814)00 (0.10608)0.19
FFP transfusion (cc)0 (0.658)0 (0.3188)0.140 (0.658)0 (0.2995)0.11
Platelet transfusion (cc)0 (0.522)0 (0.1210)0.100 (0.522)0 (0.1210)0.08
Amount of crystalloids2900 (400,9225)2600 (0,16000)0.272900 (400,9225)2500 (100,15000)0.30
Amount of colloids0 (0.3500)0 (0.3750)0.270 (0.3500)0 (0.2750)0.17
Time weighted average MAPa87 (67,128)83 (58,131)0.4487 (67,128)83 (61,125)0.39
Regional analgesia (yes)74 (3.7)709 (12.8)0.3370 (3.8)276 (15.0)0.39

Data are given as median (min, max).

Intraoperative characteristics were not considered in propensity score nor any regression modeling.

Data not available for all subjects. Time weighted average MAP = 1.

Summary Statistics of Intraoperative Characteristics. Data are given as median (min, max). Intraoperative characteristics were not considered in propensity score nor any regression modeling. Data not available for all subjects. Time weighted average MAP = 1.

Statistical analysis

The primary aim of our study was to evaluate whether surgical approach (laparoscopic vs. open) is independently associated with postoperative eGFR. Multivariable Linear Regression (MLR) was used to assess the relationship between postoperative eGFR and surgical approach in the matched sample, adjusting for covariables with ASD > 0.1 after matching. Residuals were examined to ensure there were no gross deviations from regression model assumptions. We also assessed whether laparoscopy was associated with our secondary outcome of AKI stage, adjusting for imbalanced covariables. Holm-Bonferroni step-down procedure for multiple testing adjustment was utilized to adjust the p-values from our secondary analyses. A multivariable logistic regression model on the matched data adjusted for unbalanced confounders after matching was used to estimate an adjusted Odds Ratio (OR) comparing the odds of AKI in the laparoscopic surgical procedure to those in the open group. SAS software version 9.4 (SAS Institute, Cary, NC, USA) was used for all statistical analyses.

Results

There were 16,178 adults scheduled for colorectal surgery between January 2009 and June 2016 at the Cleveland Clinic Main Campus, of whom 7,507 qualified for analysis (Fig. 1). Among those, 7,357 (98%) had complete data for the primary covariable-adjusted analysis comparing laparoscopic vs. open surgical procedures. Thus, only 2% of eligible patients (150) were excluded from consideration in the propensity score matching due to missing covariable values. Specifically, BMI was missing in 77 patients and preoperative hemoglobin was missing in 73.
Figure 1

Types and numbers of exclusions of the available colorectal surgical cases (January 2009 – June 2016) at Cleveland Clinic Foundation Main Campus.

Types and numbers of exclusions of the available colorectal surgical cases (January 2009 – June 2016) at Cleveland Clinic Foundation Main Campus. We successfully matched 1,846 laparoscopic surgical patients (93% of the total) with 1,846 open patients for a total analysis set of 3,692 surgical patients. As indicated by the Absolute standardized difference in Table 1 and the absolute standardized difference plot in Fig. 2, we were able to successfully balance all but one variable, surgeon (standardized difference = 0.14), after matching exactly on colorectal surgical type and propensity score. Therefore, we adjusted for surgeon in all subsequent regression models comparing laparoscopic vs. open surgical procedures to control for residual confounding.
Figure 2

Absolute standardized difference plot showing balance between laparoscopic and open before (red) and after (blue) matching. The vertical line at absolute standardized difference = 0.1 is the pre-specified cutoff indicating balanced (left) and imbalanced (right) variables.

Absolute standardized difference plot showing balance between laparoscopic and open before (red) and after (blue) matching. The vertical line at absolute standardized difference = 0.1 is the pre-specified cutoff indicating balanced (left) and imbalanced (right) variables. There was no association between laparoscopic approach and postoperative eGFR (Table 3). The covariable-adjusted estimate of the difference in postoperative eGFR between the laparoscopic surgical procedure and the reference open procedure was 1.1 (95% CI -0.42, 2.67) mL.min-1/1.73 m2, p = 0.15. Examination of the residuals revealed no gross deviations from multiple regression model assumptions
Table 3

Summary of raw and surgeon-adjusted associations between surgical procedure and postoperative kidney outcomes in the propensity matched analysis set.

OutcomeRaw estimates
Regression estimate (95% CI)ap-value
LaparoscopicOpen
n = 1846n = 1846
Primary
Postoperative eGFR, mL. min-1/1.73 m290 ± 2589 ± 231.1 (-0.4, 2.7)0.155
92 [76, 106]92 [74, 106]
Secondary
AKI (Any AKI vs. None)113 (6)155 (8)0.7 (0.6, 0.9)0.006b
AKIN stagesc0.7 (0.5, 0.9)0.006b
Stage 193 (5)126 (7)
Stage 214 (0.8)25 (1)
Stage 36 (0.3)4 (0.2)

Primary outcome: The raw group estimates of postoperative eGFR are mean ± SD and the regression estimate (95% CI) is the surgeon-adjusted multivariable linear regression estimated difference (laparoscopic – open) in eGFR group means. Median (Q1, Q3) of postoperative eGFR by procedure are also presented.

Secondary outcomes:

AKI (Any AKI vs. None): The raw group estimates for any acute kidney injury (AKI) are incidences of any AKI by procedure type, presented as n (%) and the regression estimate (95% CI) is the multivariable logistic regression Odds Ratio (OR) for the odds of any AKI for the laparoscopic procedures vs. the open procedures. AKIN (Stage 3, Stage 2, Stage 1, Stage 0): The raw group estimates for AKI by stage are incidences of AKI stage by procedure type, presented as n (%) and the regression estimate (95% CI) is the multivariable ordinal logistic regression OR for the odds of AKI for the laparoscopic procedures vs. the open procedures. The Chi-Square p-value for testing the proportional odds assumption suggests that this assumption was violated (p = 0.026 < 0.05), yet the results are presented as a sensitivity analysis. All p-values presented are from their respective regression analysis. The p-values for the secondary analysis were adjusted for multiple testing via Holm step-down procedure.

Surgeon-adjusted regression estimate (95% CI).

Holm-adjusted p-value.

Sensitivity analysis using AKIN Stages (0, 1, 2, 3) instead of binary AKI (Any AKI – Stages 1, 2, 3 vs. No AKI – Stage 0).

Summary of raw and surgeon-adjusted associations between surgical procedure and postoperative kidney outcomes in the propensity matched analysis set. Primary outcome: The raw group estimates of postoperative eGFR are mean ± SD and the regression estimate (95% CI) is the surgeon-adjusted multivariable linear regression estimated difference (laparoscopic – open) in eGFR group means. Median (Q1, Q3) of postoperative eGFR by procedure are also presented. Secondary outcomes: AKI (Any AKI vs. None): The raw group estimates for any acute kidney injury (AKI) are incidences of any AKI by procedure type, presented as n (%) and the regression estimate (95% CI) is the multivariable logistic regression Odds Ratio (OR) for the odds of any AKI for the laparoscopic procedures vs. the open procedures. AKIN (Stage 3, Stage 2, Stage 1, Stage 0): The raw group estimates for AKI by stage are incidences of AKI stage by procedure type, presented as n (%) and the regression estimate (95% CI) is the multivariable ordinal logistic regression OR for the odds of AKI for the laparoscopic procedures vs. the open procedures. The Chi-Square p-value for testing the proportional odds assumption suggests that this assumption was violated (p = 0.026 < 0.05), yet the results are presented as a sensitivity analysis. All p-values presented are from their respective regression analysis. The p-values for the secondary analysis were adjusted for multiple testing via Holm step-down procedure. Surgeon-adjusted regression estimate (95% CI). Holm-adjusted p-value. Sensitivity analysis using AKIN Stages (0, 1, 2, 3) instead of binary AKI (Any AKI – Stages 1, 2, 3 vs. No AKI – Stage 0). We also considered the association between surgical approach and absolute change in creatinine level from baseline (postoperative – preoperative creatinine). The difference in means for change in creatinine was not statistically different from 0: -0.01 (95% CI -0.03, 0.01), p = 0.16). Similarly, we considered the association between surgical approach and the fold change (postoperative creatinine/preoperative creatinine). The difference in fold change in creatinine was not statistically different from 0: -0.12 (95% CI -0.03, 0.01), p = 0.19. Initially, we planned to analyze AKI via multivariable ordinal logistic regression. However, the proportional odds assumption for this outcome suggested it may have been violated ( = 34, p = 0.026). Thus, we used multivariable logistic regression, modeling the odds of any AKI (Stages I, II or III) vs. no AKI adjusting for surgeon, to assess the relationship between AKI and surgical procedure. A significant protective effect of the laparoscopic procedure on the odds of having AKI was found. Patients who had laparoscopic surgeries were an estimated 0.70 (95% CI 0.55, 0.90, p = 0.006) times as likely to have AKI as open surgical patients. A similar result was observed in the proportional odds logistic model (OR (95% CI) = 0.70 [0.54, 0.90], p = 0.006). AKI Stage I (5.0% vs. 6.8%) and Stage II (0.8% vs. 1.4%) were less common in patients who had laparoscopic surgery, whereas Stage III (0.3% vs. 0.2%) was similar.

Discussion

Postoperative Acute Kidney Injury (AKI), defined by a sudden loss of renal function, affects 7% to 13% of patients having non-cardiac surgery.14, 15 Postoperative AKI is associated with significant morbidity, increased mortality, prolonged hospital and ICU stays, and high health care costs. Even small increases in creatinine after surgery are associated with a three-fold increased risk of developing end-stage renal disease and a marked increase in mortality. It is thus of considerable interest to consider whether peritoneal insufflation combined with Trendelenburg positioning impairs renal function. Although there were convincing reasons to expect an association between the surgical approach and renal injury, none was observed in our analysis. Laparoscopic surgical approach was not associated with a reduction of postoperative eGFR. Consequently, the choice of surgical approach (open vs. laparoscopic) should not be influenced by the attempt to prevent renal injury. Well known benefits of laparoscopic surgical approach including reduced blood loss, decreased postoperative pain, and shorter in-hospital recovery should be considered instead. Our secondary analyses showed that patients who had open surgery were more likely to develop AKI within the initial 48 postoperative hours in our cohort. However, about 80% of all postoperative AKI cases were Stage 1 of the AKIN criteria, considered to be “risk” rather than injury. The importance of Stage 1 AKI remains unclear. Several studies, based on limited numbers of young and relatively healthy patients, did not identify long-lasting impairment.19, 20, 21, 22 But there are other analyses that suggest increased mortality even with Stage 1 AKI.23, 24, 25 We did only detect a minor difference in AKI Stage 2 (0.8% vs. 1.4%) and no meaningful difference in AKI Stage 3 (0.3% vs. 0.2%) between the groups which is unsurprising considering the low baseline incidence of these serious outcomes. Laparoscopic procedures usually require restricted intravenous fluid administration which may have promoted hemoconcentration and slight increases in creatine that are perhaps of little physiological consequence. Consistent with this theory, our laparoscopic patients received 11 mL/minute of intravenous fluids during laparoscopic surgery compared to 13 mL/minute in the open group. Intraoperative hypotension, perioperative anemia, and preoperative use of aspirin are potential causes of postoperative kidney injury.13, 26, 27 But none of these factors seems to be likely to explain our results as blood pressures did not differ meaningfully (time weighted average mean arterial pressure 87 vs. 83 mmHg). Nor did perioperative anemia requiring blood transfusions and aspirin use differ substantively in patients with each surgical approach. It is possible that surgeons selected open surgery for patients whom they expected might need more extensive and complicated operations, which in turn would be associated with more blood loss and vasopressor use. However, there were negligible differences in blood loss and vasopressor requirements. Our analysis surely suffered from some degree of residual confounding. But we reduced the risk of selection bias by carefully matching patients on a long list of baseline characteristics. After matching, patients having each type of surgery were well balanced on most variables. In summary, laparoscopic surgical approach combined with steep Trendelenburg positioning does not appear to cause substantial renal impairment as measured by estimated glomerular filtration rate. Given the other advantages of laparoscopic surgery, the approach should not be avoided for concerns about renal injury.

Funding

Financial support was provided solely from institutional and departmental sources. None of the authors has a personal financial interest related to this analysis.

Conflicts of interest

The authors declare no conflicts of interest.
  25 in total

Review 1.  Renal physiology. Laparoscopic considerations.

Authors:  M D Dunn; E M McDougall
Journal:  Urol Clin North Am       Date:  2000-11       Impact factor: 2.241

2.  Splanchnic and renal deterioration during and after laparoscopic cholecystectomy: a comparison of the carbon dioxide pneumoperitoneum and the abdominal wall lift method.

Authors:  A M Koivusalo; I Kellokumpu; S Ristkari; L Lindgren
Journal:  Anesth Analg       Date:  1997-10       Impact factor: 5.108

3.  Laparoscopic colorectal surgery in patients with impaired renal function: impact on postoperative renal function compared with open surgery.

Authors:  Roy Inbar; Loren Swissa; Ron Greenberg; Ian White; Guy Lahat; Shmuel Avital
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2014-02-25       Impact factor: 1.878

4.  Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.

Authors:  Christian Bruch; Markus Rothenburger; Michael Gotzmann; Thomas Wichter; Hans H Scheld; Günter Breithardt; Rainer Gradaus
Journal:  Int J Cardiol       Date:  2006-10-16       Impact factor: 4.164

5.  Effect of pneumoperitoneum on renal tissue oxygenation and blood flow in a rat model.

Authors:  Joshua D Wiesenthal; Luke M Fazio; Alexandra E Perks; Brian D M Blew; David Mazer; Greg Hare; R John D'A Honey; Kenneth T Pace
Journal:  Urology       Date:  2011-04-19       Impact factor: 2.649

6.  Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus.

Authors:  J Miyazato; T Horio; S Takiuchi; K Kamide; O Sasaki; S Nakamura; H Nakahama; T Inenaga; S Takishita; Y Kawano
Journal:  Diabet Med       Date:  2005-06       Impact factor: 4.359

7.  Hemodynamic changes due to Trendelenburg positioning and pneumoperitoneum during laparoscopic hysterectomy.

Authors:  E A Hirvonen; L S Nuutinen; M Kauko
Journal:  Acta Anaesthesiol Scand       Date:  1995-10       Impact factor: 2.105

8.  Acute kidney injury and mortality 1 year after major non-cardiac surgery.

Authors:  M E O'Connor; R W Hewson; C J Kirwan; G L Ackland; R M Pearse; J R Prowle
Journal:  Br J Surg       Date:  2017-02-20       Impact factor: 6.939

9.  Determinants of postoperative acute kidney injury.

Authors:  Fernando José Abelha; Miguela Botelho; Vera Fernandes; Henrique Barros
Journal:  Crit Care       Date:  2009-05-22       Impact factor: 9.097

Review 10.  Incidence and associations of acute kidney injury after major abdominal surgery.

Authors:  M E O'Connor; C J Kirwan; R M Pearse; J R Prowle
Journal:  Intensive Care Med       Date:  2015-11-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.